GlassScriptPhysician profile
Alexander Vlahu
NPI 1699338194
$9,320.08
in general payments reported to CMS, 2019-2025
13 companies · $4,741 in 2025
The $4,741 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2021: $60.00 · 2022: $124 · 2023: $1,995 · 2024: $2,077 · 2025: $4,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,394 · Grant: $3,000 · Travel and Lodging: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,394.40 |
| Grant | $3,000.00 |
| Travel and Lodging | $2,419.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,510.00 | 2019-2025 | Actis, Ethicon, Kincise |
| Smith+Nephew, INC. | $3,012.12 | 2024-2025 | Real Intelligence |
| Stryker Corporation | $950.62 | 2024-2025 | Mako, Trident, Triathlon |
| Depuy Synthes Sales INC. | $680.48 | 2019-2025 | Na, Actis, Pinnacle Altrx |
| Zimmer Biomet Holdings, INC. | $371.43 | 2021-2025 | Oxford, Persona, Avenir |
| Skeletal Dynamics INC | $221.33 | 2023-2024 | Implate, Align, Geminus |
| Bioventus LLC | $139.09 | 2023 | Durolane |
| Encore Medical, LP | $138.51 | 2025 | |
| Vericel Corporation | $123.52 | 2022 | |
| Sanara Medtech INC. | $68.13 | 2025 | Celleraterx |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Orthalign INC | $29.34 | 2025 | Orthalign Plus |
| Medtronic, INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Vlahu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.